ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,460Medicare Part D Prescriptions Filled, Including Refills

Rank: 89 out of 973

$651K Total Retail Price of All Prescriptions

Rank: 52 out of 973

500 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 500 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 500 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 8,558 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LISINOPRIL 625 509 1 3
SIMVASTATIN 550 448 2 1
AMLODIPINE BESYLATE 496 379 3 7
LEVOTHYROXINE SODIUM 428 325 4 2
METFORMIN HCL 348 259 5 8
OMEPRAZOLE 310 260 6 5
HYDROCODONE-ACETAMINOPHEN 305 158 S3 7 4
SERTRALINE HCL 215 192 8 21
FUROSEMIDE 215 188 8 6
PRAVASTATIN SODIUM 210 171 10 22
GABAPENTIN 189 115 11 12
WARFARIN SODIUM 181 165 12 10
ATORVASTATIN CALCIUM 180 156 13 15
CRESTOR 178 95 14 34
HYDROCHLOROTHIAZIDE 175 121 15 11
LOSARTAN POTASSIUM 144 124 16 19
CARVEDILOL 139 105 17 27
FLUTICASONE PROPIONATE 137 108 18 35
TRAMADOL HCL 118 69 19 18
GLIMEPIRIDE 117 92 20 41
NEXIUM 113 70 21 30
ALLOPURINOL 108 103 22 29
LANTUS 102 60 23 39
TAMSULOSIN HCL 101 90 24 28
POTASSIUM CHLORIDE 101 89 24 9
TRAZODONE HCL 95 59 26 48
PROAIR HFA 94 27 27 54
METOPROLOL SUCCINATE 94 77 27 17
ATENOLOL 93 86 29 16
CITALOPRAM HBR 88 74 30 14
ALENDRONATE SODIUM 86 70 31 24
METOPROLOL TARTRATE 77 63 32 13
OXYBUTYNIN CHLORIDE 74 46 33 92
OXYCODONE HCL-ACETAMINOPHEN 74 62 S2 33 104
CYCLOBENZAPRINE HCL 68 25 R 35 42
MELOXICAM 67 51 36 23
OXYCODONE-ACETAMINOPHEN 66 50 S2 37 89
ACTOS 64 49 38 119
DONEPEZIL HCL 64 64 38 26
OXYCODONE HCL 63 0 S2 40 79
LEVEMIR FLEXPEN 61 35 41 204
LEVOFLOXACIN 61 47 41 84
ESCITALOPRAM OXALATE 61 37 41 68
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 50 44 25
AZITHROMYCIN 57 37 45 47
NAMENDA 57 57 45 31
NOVOLOG 52 37 47 82
DOXAZOSIN MESYLATE 52 41 47 87
PANTOPRAZOLE SODIUM 51 47 49 37
LOSARTAN-HYDROCHLOROTHIAZIDE 51 43 49 46
CLOPIDOGREL 51 48 49 44
JANUVIA 51 47 49 88
ZOLPIDEM TARTRATE 50 42 53 20
METFORMIN HCL ER 50 34 53 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 14, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.